PHR1817
Furosemide Related Compound A
Pharmaceutical Secondary Standard; Certified Reference Material
Sinônimo(s):
2-Chloro-4-furfurylamino-5-sulfamoylbenzoic acid, 2-CHLORO-4-N-FURFURYLAMINO -5-SULFAMOYLBENZOIC ACID
About This Item
Produtos recomendados
grau
certified reference material
pharmaceutical secondary standard
Nível de qualidade
Agency
traceable to Ph. Eur. F0702000
traceable to USP 1287020
Certificado de análise (CofA)
current certificate can be downloaded
embalagem
pkg of 100 mg
pf
197 °C (dec.) (lit.)
aplicação(ões)
pharmaceutical
formato
neat
temperatura de armazenamento
2-30°C
cadeia de caracteres SMILES
OC(C1=C(Cl)C=C(NCC2=CC=CO2)C(S(N)(=O)=O)=C1)=O
InChI
1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)11(21(14,18)19)4-8(9)12(16)17/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)
chave InChI
UXOOVYKVEXGCSH-UHFFFAOYSA-N
Procurando produtos similares? Visita Guia de comparação de produtos
Categorias relacionadas
Descrição geral
Aplicação
- Furosemide Impurity A for Quality Control: Furosemide Related Compound A serves as a crucial standard in pharmaceutical quality control, ensuring the purity and safety of furosemide as an active pharmaceutical ingredient. This impurity standard is essential for regulatory compliance and batch-to-batch consistency in drug manufacturing (Abasilim et al., 2023).
- Research on Drug Resistance: Furosemide Related Compound A is utilized in genomic research to identify potential drug resistance mechanisms. This research aids in understanding how bacterial pathogens develop resistance to drugs like clarithromycin and rifampicin, which is crucial for developing new therapeutic strategies (Mofidifar et al., 2024).
- Nanotechnology in Drug Delivery: High-purity Furosemide Related Compound A is used in the preparation and characterization of novel drug delivery systems, such as nanoparticles designed to enhance the bioavailability and efficacy of pharmaceutical compounds. This research highlights its application in improving drug formulations and targeting specific disease sites (Zeng et al., 2024).
- Impact on Bone Health: Research involving Furosemide Related Compound A explores its effects on bone health, particularly in how it influences vitamin D metabolism and bone density. This is vital for developing treatments that mitigate bone density loss associated with long-term use of diuretics like furosemide (Melanie KF et al., 2024).
- Nutritional Studies in Cancer Therapy: Furosemide Related Compound A is also examined for its role in nutritional interventions in cancer therapy, particularly its impact on the nutritional status of patients undergoing surgery for colorectal cancer. These studies are crucial for understanding how nutritional support can enhance recovery and treatment outcomes in cancer patients (Ural et al., 2024).
Nota de análise
Outras notas
Nota de rodapé
Produtos recomendados
Código de classe de armazenamento
11 - Combustible Solids
Classe de risco de água (WGK)
WGK 3
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Choose from one of the most recent versions:
Certificados de análise (COA)
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica